Adrian Dana, M.D.

Adrian Dana joined Jasper in 2024 as Vice President, Drug Safety and Pharmacovigilance. Dr. Dana is an experienced pharmaceutical physician with over 20 years of global safety, pharmacovigilance, risk management and medical affairs experience, and has participated in the initial filings and ultimate licensure for over 11 NMEs in vaccines, infectious diseases, oncology, rare diseases, and allergy. Dr. Dana previously served as VP of Drug Safety at Flatiron Health, where she developed solutions for using real-world evidence for drug safety. Prior to Flatiron, she was VP, Head of Safety at Aimmune and at Alnylam, and before that she spent 10 years at Merck where she pioneered the Risk Management systems. Dr. Dana received her M.D. from the Medical College of Pennsylvania and her Bachelor of Arts in Biology from Ursinus College.